# ANDA Submissions – Amendments and Requests for Final Approval to Tentatively Approved ANDAs:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/anda-submissions-amendments-and-requests-for-final-approval-to-tentatively-approved-andas-guidance-for-industry/eac298b4-7442-4924-b433-f71c0be0a2f6

> FDA guidance document: ANDA Submissions – Amendments and Requests for Final Approval to Tentatively Approved ANDAs:  Guidance for Industry. Issue date: January 24, 2024. Get complete insights and analysis.

---

## Details

- Title: ANDA Submissions – Amendments and Requests for Final Approval to Tentatively Approved ANDAs:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2024-01-24
- Last Changed: 2024-01-24
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2018-D-4726">FDA-2018-D-4726</a>

## Related Documents

- [Controlled Correspondence Related to Generic Drug Development](https://www.globalkeysolutions.net/guidances/guidance-document/controlled-correspondence-related-to-generic-drug-development/55babf6e-6cea-4e6c-80f6-3892feff9aab)
- [Good ANDA Submission Practices Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/good-anda-submission-practices-guidance-for-industry/c4f8f27a-3522-470b-8889-206366ebc0e7)
- [ANDA Submissions | Amendments to Abbreviated New Drug Applications Under GDUFA:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/anda-submissions-amendments-to-abbreviated-new-drug-applications-under-gdufa-guidance-for-industry/9fe16cd4-ef07-4dd1-8241-a762f71acbb7)